Showing results (2601-2610 of 2,722) with videos related to
Sort By:
Pageof 273
Current Oncology (Toronto, Ont.)|February 24, 2022
Report from the Western Canadian Gastrointestinal Consensus Cancer Conference-Management of Total Neoadjuvant Therapy in Rectal CancerHoward Lim, Aswin George Abraham, Shahid Ahmed, et al.JAMA Network Open|February 28, 2023
Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron WavesMargaret K Doll, Alpana Waghmare, Antje Heit, et al.Current Oncology (Toronto, Ont.)|April 25, 2015
Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014S Ahmed, O Bathe, S Berry, et al.JCI Insight|November 24, 2025
A shift in PKM2 oligomeric state instructs adipocyte inflammatory potentialMichelle Sma Damen, Pablo C Alarcon, Calvin C Chan, et al.Stem Cell Reports|November 15, 2016
CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full MutationsUrszula Brykczynska, Eline Pecho-Vrieseling, Anke Thiemeyer, et al.Leukemia|November 7, 2025
Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving conceptK S Kurz, A Zamo, C Drewes, et al.Biomedicines|November 25, 2023
On- vs. Off-Pump CABG in Heart Failure Patients with Reduced Ejection Fraction (HFrEF): A Multicenter AnalysisChristian Jörg Rustenbach, Stefan Reichert, Medhat Radwan, et al.Journal of Medicinal Chemistry|January 22, 1998
Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compoundsF G Njoroge, B Vibulbhan, D F Rane, et al.Cell Metabolism|October 2, 2018
Mechanisms Preserving Insulin Action during High Dietary Fat IntakeAnne-Marie Lundsgaard, Jacob B Holm, Kim A Sjøberg, et al.Journal of Medicinal Chemistry|June 23, 1999
Tricyclic farnesyl protein transferase inhibitors: crystallographic and calorimetric studies of structure-activity relationshipsC L Strickland, P C Weber, W T Windsor, et al.Pageof 273